GXP-PHARMA SUPPORT ApS: Financial statements 2024
CVR: 36033347
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
GXP-PHARMA SUPPORT ApS (CVR 36033347) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -262,786 and a net result of DKK -166,431 compared with DKK 367,356 the year before. Equity in the 2024 report amounted to DKK 373,246. The solvency ratio was 57.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -262,786
- Profit/Loss
- DKK -166,431
- Equity
- DKK 373,246
- Total Assets
- DKK 646,158
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -263 t. | -166 t. | 373 t. | 1 |
| 2023 | - | 361 t. | 367 t. | 1.1 mio. | 1 |
| 2022 | - | 211 t. | -346 t. | 772 t. | 1 |
| 2021 | - | 1.1 mio. | 426 t. | 1.1 mio. | 1 |
| 2020 | - | 1 mio. | 664 t. | 1.7 mio. | 1 |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
GXP-PHARMA SUPPORT ApS has published its annual report for 2023. Gross profit came to DKK 360,871, and the net result was DKK 367,356.
About GXP-PHARMA SUPPORT ApS
GXP-PHARMA SUPPORT ApS is a Danish company of the type Anpartsselskab based in Sorø, founded in 2014. The company is registered under the industry Anden teknisk rådgivning. The company was previously named GXP-PHARMA SUPPORT A/S. The management consists of Lone Cleveland Andersen. The board consists of Jan Laursen (chair), Iben Cleveland Laursen and Lone Cleveland Andersen. The company is owned by CHRIBEN ApS. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK 128,518 and a net result of DKK -314,498 compared with DKK -166,431 the year before. Equity in the 2025 report amounted to DKK 58,748.